University of Groningen
Also known as: Academisch Ziekenhuis Groningen | Accare Child Study Center; University Medical Center Groningen; University of Groningen | Barbara Horváth, Principal Investigator | Clinical Immunology, Groningen University Hospital, Netherlands | Commissie Voor Klinisch Toegepast Onderzoek | Consultant pediatrician metabolic diseases | Department of Clinical Pharmacy and Pharmacology University Medical Centre Groningen | Department of Critical Care, UMCG | Department of Dermatology, University Medical Center Groningen | Department of Neurology, University Medical Centre Groningen, the Netherlands | Department of Surgery, University Medical Centre Groningen, Groningen, Netherlands | Dept of Neuroscience/ Neuroimaging Center Groningen | Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands | Dept. of Pulmonary Medicine and Tuberculosis - University of Groningen - The Netherlands | dr. DJ Mulder | Gertrude J. Nieuwenhuijs-Moeke | Groningen Institute for Asthma and COPD | Groningen Research Institute for Asthma and COPD | Groningen University | Heleen Grootjans | Huib A.M. Kerstjens | Jan-Willem C Alffenaar | Marieke Duiverman | Martini Hospital Groningen | Medical Microbiology UMCG Groningen | MMRF Struys | M.p. van den Berg, MD, PhD, professor in Cardiology | Municipality of Midden-Groningen, the Netherlands | Ommelander Ziekenhuis Groningen | Pediatric Hematology/Oncology, University Children's Hospital, Groningen, The Netherlands | prof. Peter de Jonge | The Collaborative Study Group, University of Groningen, NETHERLANDS | Thorax Centre, University Medical Centre Groningen | UMCG | UMCG, Department of Cardiology | UMCG Groningen | UMCG / HOVON | UMC Groningen | UMCG, University Hospital (Groningen, The Netherlands) | Univeristy Medical Center Groningen | Universitary Medical Center Groningen | Universit Medical Center Groningen | University Hospital Groningen, Dept. of Hematology | University Hospital Medical center, university of groningen | University Medical Center Groningen | University Medical Center Groningen and Erasmus University Medical Center | University Medical Center Groningen, Department of Neurology, Alzheimer Center Groningen | University Medical Center Groningen, Department of Pulmonary Diseases | University Medical Center Groningen, Dept. of Anaesthesiology | University Medical Center Groningen, Dept of Cardiology | University Medical Center Groningen, Dept. of Cardiology | University Medical Center Groningen, Dept. of Cardiothoracic Surgery | University Medical Center Groningen, Dept. of Experimental Cardiology | University Medical Center Groningen, Dept. of Exprimental Cardiology | University Medical Center Groningen, NL | University Medical Center Groningen, The Netherlands | University Medical Center Groningen (UMCG) | University Medical Center Groningen, UMCG | University Medical Center Groningen UMCG, The Netherlands | University Medical Centre | University Medical Centre Grongingen | University Medical Centre Groningen | University Medical Centre Groningen, Dept. of Cardiology | University Medical Centre, Groningen, The Netherlands | University Medical Centre Groningen, University of Groningen, the Netherlands | University of Groningen | University of Groningen, University Medical Centre Groningen | Unversity Medical Center Groningen | Wouter van Geffen
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1995Last known activity
Mar 2, 2026
Timeline
1610s
- Jan 1, 1614
University of Groningen— Founded
Drugs by trial phase (304 distinct, 322 trials)
Phase 4 (66 own, 0 via acquisition)
Phase 3 (84 own, 0 via acquisition)
Phase 2 (90 own, 0 via acquisition)
Phase 1 (19 own, 0 via acquisition)
Other trials (45 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Adenocarcinoma
- Adenoma
- Adenomatous Polyposis Coli
- Adnexal Diseases
- Adrenal Insufficiency
- Albuminuria
- Alzheimer Disease
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Aneurysm
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Asthma
- Atrial Fibrillation
- Barrett Esophagus
- Biliary Tract Diseases
- Brain Diseases
- Brain Neoplasms
- Breast Neoplasms
- Bronchiectasis
- Bronchiolitis
- Bronchiolitis Obliterans
- Buruli Ulcer
- Candidiasis
- Candidiasis, Invasive
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Cardiomyopathies
- Cardiovascular Diseases
- Cholangiocarcinoma
- Cholangitis
- Cholangitis, Sclerosing
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Crohn Disease
- Cystic Fibrosis
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Digestive System Diseases
- Digestive System Neoplasms
- Dyspnea
- Eczema
- Edema
- Embolism
- Endometrial Neoplasms
- Endometriosis
- End Stage Liver Disease
- Esophageal Neoplasms
- Extensively Drug-Resistant Tuberculosis
- Fever
- Fibrosis
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Giant Cell Arteritis
- Glioblastoma
- Glycogen Storage Disease
- Glycogen Storage Disease Type I
- Granulomatosis with Polyangiitis
- Hallucinations
- Head and Neck Neoplasms
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Heart Failure, Diastolic
- Hemorrhage
- Hepatic Encephalopathy
- Hepatitis C
- Hidradenitis
- Hidradenitis Suppurativa
- HIV Infections
- Hodgkin Disease
- Hypertension
- Hypertension, Portal
- Hypertension, Pulmonary
- Infarction
- Infections
- Inflammation
- Inflammatory Bowel Diseases
- Influenza, Human
- Insulin Resistance
- Intestinal Diseases
- Intracranial Aneurysm
- Invasive Fungal Infections
- Kidney Diseases
- Klatskin Tumor
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Liver Cirrhosis
- Liver Diseases
- Liver Failure
Recent trials (50)
- NCT07206290Lead sponsorPhase 2Mar 2, 2026
- NCT07304817Lead sponsorPhase 2Feb 28, 2026
- NCT07258641Lead sponsorPhase 1/Phase 2Jan 15, 2026
- NCT07196384CollaboratorPhase 1Dec 15, 2025
- NCT07196384Lead sponsorPhase 1Dec 15, 2025
- NCT07181135Lead sponsorPhase 3Dec 1, 2025
- NCT07181135OfficialPhase 3Dec 1, 2025
- NCT06982300Lead sponsorPhase 1/Phase 2Sep 25, 2025
- NCT07108855Lead sponsorPhase 1/Phase 2Sep 1, 2025
- NCT07239570CollaboratorPhase 4Jun 20, 2025
- NCT06809946Lead sponsorPhase 1/Phase 2Jun 1, 2025
- NCT06923475CollaboratorPhase 2/Phase 3May 5, 2025
- NCT06887621CollaboratorPhase 2Apr 10, 2025
- NCT07206017Lead sponsorN/AMar 26, 2025
- NCT07206017OfficialN/AMar 26, 2025
Details
- Founded
- Groningen, NL Jan 1, 1614
- Last known activity
- Mar 2, 2026